|
Submission ROB-UNI-718ed485
|
|
0
|
132
|
April 15, 2021
|
|
Submission ROB-UNI-f098ae62
|
|
0
|
111
|
April 15, 2021
|
|
Submission ROB-UNI-30edb307
|
|
0
|
119
|
April 15, 2021
|
|
Submission PET-UNK-03fd2068
|
|
0
|
123
|
April 14, 2021
|
|
Submission PET-UNK-f4e47ebd
|
|
0
|
119
|
April 12, 2021
|
|
Submission ALP-UNI-58319883
|
|
0
|
159
|
April 12, 2021
|
|
Submission MAT-POS-fc9ede84
|
|
0
|
148
|
April 12, 2021
|
|
Submission PET-UNK-d9de6a0b
|
|
3
|
224
|
April 11, 2021
|
|
Submission PET-UNK-e5587e5d
|
|
0
|
125
|
April 11, 2021
|
|
Submission MIC-UNK-5b1ead09
|
|
0
|
120
|
April 10, 2021
|
|
Submission EDJ-MED-7587a9ee
|
|
1
|
406
|
April 10, 2021
|
|
Submission MAT-POS-64942dd0
|
|
0
|
146
|
April 9, 2021
|
|
Submission ROB-UNI-7b37d95b
|
|
0
|
142
|
April 9, 2021
|
|
Submission ROB-UNI-269bf23d
|
|
0
|
123
|
April 9, 2021
|
|
Submission ROB-UNI-8bf7c232
|
|
0
|
137
|
April 9, 2021
|
|
Submission ALP-POS-347519b5
|
|
0
|
126
|
April 9, 2021
|
|
Submission ALP-UNI-dbb9503d
|
|
0
|
166
|
April 8, 2021
|
|
Submission BEN-DND-d1eb1f41
|
|
0
|
140
|
April 8, 2021
|
|
Submission RAL-THA-eb6cb89c
|
|
0
|
145
|
April 8, 2021
|
|
Submission EDJ-MED-923a35c2
|
|
0
|
132
|
April 8, 2021
|
|
Pfizer protease inhib. pill trials
|
|
4
|
226
|
April 7, 2021
|
|
Submission DAR-DIA-06c53477
|
|
0
|
148
|
April 6, 2021
|
|
Submission MIC-UNK-6e9f8a43
|
|
0
|
144
|
April 6, 2021
|
|
Conformations of tetrahydroisoquinoline sulfonamide (e.g. MAT-POS-dd3ad2b5-4)
|
|
2
|
461
|
April 5, 2021
|
|
Submission JOH-IMS-1436231f
|
|
0
|
146
|
April 4, 2021
|
|
Submission MAT-POS-a5ef2d74
|
|
0
|
125
|
April 3, 2021
|
|
Submission JOH-IMS-62aeb97d
|
|
0
|
125
|
April 3, 2021
|
|
Submission JOH-IMS-cc7b4c67
|
|
0
|
156
|
April 3, 2021
|
|
Submission JOH-IMS-0f19a540
|
|
0
|
131
|
April 3, 2021
|
|
Submission PET-UNK-10c83c8b
|
|
0
|
147
|
April 3, 2021
|